Projects per year
Personal profile
Education
- 2018 PhD, Graduate Institute of Clinical Medicine, College of Medicine, National Yang-Ming University
- 2003 MD, College of Medicine, National Defense Medical Center
Experience
- Director, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Director, Division of Gynecology, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Attending, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Associate Professor, Department of Obstetrics & Gynecology, School of Medicine, College of Medicine, Taipei Medical University
- Attending, Department of Obstetrics & Gynecology,Taipei Veterans General Hospital
Fingerprint
Dive into the research topics where Kuo-Chang Wen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Discovery of New Dna Methylation Biomarkers to Improve the Performance of Self-Sampling Mpap (Mpap 2.0) (1/2)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
利用卵巢癌幹細胞分化模型建立漿液性卵巢上皮癌表基因分類系統
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
人類子宮內膜癌淋巴結轉移的分子預測
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
Periureteral liposarcoma causes of hydroureter and hydronephrosis: An unpredictable diagnosis
Lin, T. E., Wen, K. C., Lai, H. C. & Chu, L. H., Jan 2023, In: Gynecology and Minimally Invasive Therapy. 12, 1, p. 51-54 4 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Article Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis
Chen, L. Y., Huang, R. L., Su, P. H., Lai, H. C., Wen, K. C., Chu, L. H., Weng, Y. C. & Wang, H. C., May 1 2022, In: International journal of molecular sciences. 23, 9, 5120.Research output: Contribution to journal › Article › peer-review
Open Access -
Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study
Wen, K. C., Huang, R. L., Chen, L. Y., Wu, T. I., Lu, C. H., Chu, T. Y., Ou, Y. C., Wu, C. H., Hsu, S. T., Ding, D. C., Chu, L. H., Chen, C. W., Chang, H. C., Liu, Y. S., Wang, H. C., Weng, Y. C., Su, P. H., Lin, H. & Lai, H. C., Sept 2022, In: Cancers. 14, 17, 4343.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis
Chu, L. H., Liao, C. C., Liew, P. L., Chen, C. W., Su, P. H., Wen, K. C., Lai, H. C., Huang, R. L. & Chen, L. Y., Jun 1 2022, In: International journal of molecular sciences. 23, 11, 5973.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Prenatal case of RIT1 mutation associated Noonan syndrome by whole exome sequencing (WES) and review of the literature
Qiu, Z., Chang, W. T., Chou, Y. C., Wen, K. C., Ziying, Y., Yuen, K., Cai, X., Chang, T. Y., Lai, H. C. & Sung, P. L., 2022, (Accepted/In press) In: Taiwanese Journal of Obstetrics and Gynecology.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus)
Datasets
-
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C. F. (Contributor), Lin, J. (Contributor), Wu, A. T. (Creator), Sung, P. (Contributor), Lee, M. (Contributor), Yeung, S. J. (Contributor), Chou, P. (Contributor) & Wen, K. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845528.v1, https://doi.org/10.6084%2Fm9.figshare.12845528.v1
Dataset
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y. (Contributor), Wen, K. (Creator), Sung, P. (Contributor), Chou, Y. (Creator), Liew, P. (Contributor), Chen, L. (Contributor), Huang, R. (Creator), Lai, H. (Contributor) & Chang, L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
Dataset
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M. (Contributor), Yeung, S. J. (Contributor), Chou, P. (Contributor), Lin, J. (Contributor), Wen, K. (Creator), Huang, C. F. (Contributor), Sung, P. (Contributor) & Wu, A. T. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
Dataset
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chou, P. (Contributor), Wu, A. T. (Creator), Sung, P. (Contributor), Huang, C. F. (Contributor), Lin, J. (Contributor), Wen, K. (Creator), Yeung, S. J. (Contributor) & Lee, M. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://doi.org/10.6084%2Fm9.figshare.12845522.v1
Dataset
-
Additional file 4 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M. (Contributor), Wu, A. T. (Creator), Yeung, S. J. (Contributor), Wen, K. (Creator), Chou, P. (Contributor), Huang, C. F. (Contributor), Lin, J. (Contributor) & Sung, P. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845531.v1, https://doi.org/10.6084%2Fm9.figshare.12845531.v1
Dataset